K Zorena

Summary

Publications

  1. pmc Serum concentrations of transforming growth factor-Beta 1 in predicting the occurrence of diabetic retinopathy in juvenile patients with type 1 diabetes mellitus
    Katarzyna Zorena
    Department of Clinical and Experimental Endocrinology, Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Powstania Styczniowego 9B, 81 519 Gdynia, Poland
    J Diabetes Res 2013:614908. 2013
  2. pmc Relationship between serum transforming growth factor β 1 concentrations and the duration of type 1 diabetes mellitus in children and adolescents
    Katarzyna Zorena
    Department of Clinical and Experimental Endocrinology, Institute of Maritime and Tropical Medicine, Medical University of Gdansk, 81 519 Gdynia, Poland
    Mediators Inflamm 2013:849457. 2013
  3. pmc Biomarkers in diabetic retinopathy and the therapeutic implications
    Katarzyna Zorena
    Department of Clinical and Experimental Endocrinology, Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Powstania Styczniowego 9B, 81 519 Gdynia, Poland
    Mediators Inflamm 2013:193604. 2013
  4. doi request reprint Threshold serum concentrations of tumour necrosis factor alpha (TNFα) as a potential marker of the presence of microangiopathy in children and adolescents with type 1 diabetes mellitus (T1DM)
    Katarzyna Zorena
    Department of Clinical and Experimental Endocrinology, Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Poland
    Hum Immunol 74:75-81. 2013
  5. pmc Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus
    K Zorena
    Department of Immunology, Medical University of Gdansk, Gdansk, Poland
    J Hum Hypertens 24:755-62. 2010
  6. doi request reprint Interleukin-12 and tumour necrosis factor-alpha equilibrium is a prerequisite for clinical course free from late complications in children with type 1 diabetes mellitus
    K Zorena
    Department of Immunology, Medical University of Gdansk, Gdansk, Poland
    Scand J Immunol 67:204-8. 2008
  7. ncbi request reprint Significance of tumor necrosis factor alpha in patients with long-standing type-I diabetes mellitus
    J Mysliwska
    Department of Histology and Immunology, Medical University of Gdansk, Poland
    Horm Metab Res 30:158-61. 1998

Collaborators

Detail Information

Publications8

  1. pmc Serum concentrations of transforming growth factor-Beta 1 in predicting the occurrence of diabetic retinopathy in juvenile patients with type 1 diabetes mellitus
    Katarzyna Zorena
    Department of Clinical and Experimental Endocrinology, Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Powstania Styczniowego 9B, 81 519 Gdynia, Poland
    J Diabetes Res 2013:614908. 2013
    ..94. The sensitivity and specificity were calculated to be 72% and 88%, respectively. Our results suggest that TGF- β 1 serum concentrations may be an additional parameter in predicting the occurrence of DR in juvenile patients with T1DM...
  2. pmc Relationship between serum transforming growth factor β 1 concentrations and the duration of type 1 diabetes mellitus in children and adolescents
    Katarzyna Zorena
    Department of Clinical and Experimental Endocrinology, Institute of Maritime and Tropical Medicine, Medical University of Gdansk, 81 519 Gdynia, Poland
    Mediators Inflamm 2013:849457. 2013
    ..The results of our study indicate that serum TGF- β 1 concentrations are one of the factors that may have an impact on the progression of vascular complications in children and adolescents with T1DM. ..
  3. pmc Biomarkers in diabetic retinopathy and the therapeutic implications
    Katarzyna Zorena
    Department of Clinical and Experimental Endocrinology, Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Powstania Styczniowego 9B, 81 519 Gdynia, Poland
    Mediators Inflamm 2013:193604. 2013
    ..At present, it is antivascular endothelial growth factor and antitumor necrosis factor that gain particular significance. ..
  4. doi request reprint Threshold serum concentrations of tumour necrosis factor alpha (TNFα) as a potential marker of the presence of microangiopathy in children and adolescents with type 1 diabetes mellitus (T1DM)
    Katarzyna Zorena
    Department of Clinical and Experimental Endocrinology, Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Poland
    Hum Immunol 74:75-81. 2013
    ..7% and 94.3%, respectively. In conclusion, according to our results serum TNFα concentrations over 1.7 pg/ml may point to the presence of diabetic microangiopathy in children and adolescents T1DM...
  5. pmc Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus
    K Zorena
    Department of Immunology, Medical University of Gdansk, Gdansk, Poland
    J Hum Hypertens 24:755-62. 2010
    ..Summarizing, the measurement of VEGF serum levels allows for the identification of groups of patients who have the highest risk of HT and, subsequently, progression of vascular complications...
  6. doi request reprint Interleukin-12 and tumour necrosis factor-alpha equilibrium is a prerequisite for clinical course free from late complications in children with type 1 diabetes mellitus
    K Zorena
    Department of Immunology, Medical University of Gdansk, Gdansk, Poland
    Scand J Immunol 67:204-8. 2008
    ..It may suggest that a disharmony between pro- and anti-angiogenic function of these cytokines underlie the mechanism by which TNF-alpha and IL-12 shape the disease course...
  7. ncbi request reprint Significance of tumor necrosis factor alpha in patients with long-standing type-I diabetes mellitus
    J Mysliwska
    Department of Histology and Immunology, Medical University of Gdansk, Poland
    Horm Metab Res 30:158-61. 1998
    ..We suggest that TNFalpha released systemically in diabetic patients stimulates the hypophysis-adrenal axis, and in that way indirectly ameliorates autoimmune response occurring during the advanced phase of the disease...